ANTI-INHIBITOR COAGULANT COMPLEX, FACTOR EIGHT INHIBITOR BYPASSING ACTIVITY (FEIBA) (an tee-in HIB it or kow A gyuh luhnt KOM pleks, fak TER ayt in HIB it or BYE pas ing AK tiv it ee (FEE ba)) prevents and treats bleeding episodes in people with hemophilia, a condition caused by low levels of blood clotting factors.


There is no lifestyle interaction information available for this medication.